Bio­phar­ma shares ral­ly as Don­ald Trump scores a stun­ning up­set

As a can­di­date for pres­i­dent, Hillary Clin­ton’s tweets about rein­ing in ris­ing drug prices helped ice over shares for biotech com­pa­nies over the course of the year. And now that she’s been de­feat­ed by Don­ald Trump, in­vestors are re­spond­ing by dri­ving shares up in re­lief that it will be the Re­pub­li­can that will have his hands on health­care pol­i­cy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.